현재 위치:홈 > 뉴스현황 > Press Events > Newly Discovered Cel...
저자: 업로드:2017-06-20 조회수:
An international research
team reports the discovery of a new cellular pathway that can promote and
support the growth of cancer cells. In a mouse model of melanoma, blocking this
pathway resulted in reduction of tumor growth.
The study ("Transcriptional Activation of RagD GTPase Controls mTORC1 and Promotes Cancer Growth"), which is published in Science, offers a novel opportunity to develop drugs that could potentially inhibit this pathway in human cancer cells and help control their growth.
"We had been studying components of this pathway for several years," said senior author Andrea Ballabio, M.D., professor of molecular and human genetics at Baylor College of Medicine and Texas Children's Hospital in Houston, and director of the Telethon Institute of Genetics and Medicine in Naples, Italy. "We know that the pathway is important for normal cells to carry on their activities as it is involved in regulating metabolism, that is, how cells process nutrients to obtain energy and how cells use energy to grow. In this study, we wanted to learn more about how the pathway regulates its activity."
Pathways involved in cellular metabolism typically regulate themselves, meaning that some components of the pathway control each other's activities. "We suspected that the pathway was autoregulated, and we confirmed it in this study," added Dr. Ballabio. "Our experimental approaches showed that there is a feedback loop within the path that allows it to control itself."
He and his collaborators
studied the role of the pathway in two normal cellular activities—how cells
respond to physical exercise and how they respond to nutrient availability. In
terms of physical exercise, the researchers determined that the self-regulating
mechanism they discovered is essential for the body builder effect.
"Some athletes take the amino acid leucine or a mixture of amino acids immediately after exercising, which promotes protein synthesis that leads to muscle growth. This is the body builder effect," explained Dr. Ballabio. "When we genetically engineered mice to lack the pathway, we lost the body builder effect."